6 days ago
ABBV
AnalystsTerence FlynnTerence Flynn's Stock Forecasts
AnalystsTerence Flynn
Sectors:
Analyst Ranking
Top 5%
#259 out of 5556 analysts
Average Return
+16.2%
Win Rate
63%102 out of 161
Risk vs Reward
Poor
Good
Terence Flynn's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alumis IncALMS | +432.84% | $4.75 | $25.31 | 2025-08-15 - 2026-08-14 | Strong Buy |
Arcus Biosciences IncRCUS | +157.85% | $8.28 | $21.35 | 2025-05-09 - 2026-01-08 | Strong Buy |
Translate Bio IncTBIO1 | +147.91% | $15.07 | $37.36 | 2020-10-05 - 2021-09-14 | Strong Buy |
Blueprint Medicines CorpBPMC | +140.20% | $41.34 | $99.30 | 2017-03-13 - 2018-03-13 | Strong Buy |
Eli Lilly & CoLLY | +139.90% | $314.17 | $753.68 | 2023-03-01 - 2024-02-29 | Strong Buy |
Terence Flynn Analyst Color
Get additional color on Terence Flynn's coverage of popular stocks
a month ago
RPRX
a month ago
LLY
a month ago
BMY
a month ago
ABBV
3 months ago
MRK
3 months ago
MRNA
3 months ago
MRK
3 months ago
NRIX
4 months ago
LLY
6 months ago
VRTX
6 months ago
ABBV
7 months ago
VRTX
7 months ago
RPRX
7 months ago
LLY
8 months ago
ALMS
8 months ago
VRTX
10 months ago
NRIX
10 months ago
ALMS
a year ago
BMY
a year ago
MRK
a year ago
GPCR
a year ago
AMGN
a year ago
ABBV
a year ago
LLY
Terence Flynn's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Biontech SeBNTX | 10 | Strong Buy | $106.00 | +21.13% | Maintains | 4 days ago |
Amgen IncAMGN | 19 | Hold | $410.00 | -10.95% | Maintains | 4 days ago |
Vertex Pharmaceuticals IncVRTX | 8 | Strong Buy | $660.00 | +20.64% | Maintains | 5 days ago |
Biohaven LtdBHVN | 8 | Strong Buy | $21.00 | +45.03% | Maintains | 5 days ago |
Abbvie IncABBV | 24 | Strong Buy | $346.00 | +18.77% | Maintains | 6 days ago |
Eli Lilly & CoLLY | 26 | Strong Buy | $1,596.00 | +17.87% | Maintains | 9 days ago |
Bristol Myers Squibb CoBMY | 13 | Strong Sell | $40.00 | -35.63% | Maintains | 9 days ago |
Johnson & JohnsonJNJ | 32 | Strong Buy | $292.00 | +5.71% | Maintains | 24 days ago |
United Therapeutics CorpUTHR | 13 | Hold | $566.00 | +0.71% | Maintains | a month ago |
Royalty Pharma PLCRPRX | 15 | Strong Buy | $67.00 | -0.45% | Maintains | a month ago |
Moderna IncMRNA | 2 | Hold | $95.00 | -62.63% | Maintains | a month ago |
Merck & Co IncMRK | 23 | Strong Buy | $177.00 | +20.63% | Maintains | a month ago |
Alumis IncALMS | 5 | Strong Buy | $29.00 | +380.93% | Maintains | 2 months ago |
Nurix Therapeutics IncNRIX | 8 | Strong Buy | $38.00 | +148.37% | Maintains | 3 months ago |
Arcus Biosciences IncRCUS | 10 | Hold | $22.00 | +20.35% | Maintains | 6 months ago |
Intellia Therapeutics IncNTLA | 6 | Hold | $15.00 | +32.16% | Maintains | 6 months ago |
Pfizer IncPFE | 22 | Hold | $28.00 | -4.73% | Maintains | 7 months ago |
Structure Therapeutics IncGPCR | 2 | Strong Buy | $125.00 | +514.25% | Maintains | a year ago |
Organon & CoOGN | 11 | Hold | $9.00 | -35.11% | Maintains | a year ago |
Arvinas IncARVN | 8 | Hold | $11.00 | N/A | Maintains | a year ago |
Crispr Therapeutics AgCRSP | 7 | Strong Sell | $32.00 | N/A | Maintains | 2 years ago |
Blueprint Medicines CorpBPMC | 5 | Strong Buy | $168.00 | N/A | Maintains | 3 years ago |
C4 Therapeutics IncCCCC | 5 | Hold | $8.00 | N/A | Maintains | 3 years ago |
Revance Therapeutics IncRVNC | 7 | Hold | $12.00 | N/A | Maintains | 3 years ago |
Neuehealth IncNEUE | 1 | Strong Buy | $2,880.00 | N/A | Initiates Coverage On | 5 years ago |
Biogen IncBIIB | 2 | Hold | $436.00 | N/A | Maintains | 5 years ago |
Translate Bio IncTBIO1 | 1 | Strong Buy | $342.00 | N/A | Initiates Coverage On | 6 years ago |
Acceleron Pharma IncXLRN | 2 | Hold | $40.00 | N/A | Upgrades | 8 years ago |
Alnylam Pharmaceuticals IncALNY | 1 | Strong Buy | N/A | N/A | Upgrades | 9 years ago |
Kyntra Bio IncKYNB | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Bioverativ IncBIVV | 1 | Hold | N/A | N/A | Downgrades | 10 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.